Xing Wu Selected Research

Biomarkers (Surrogate Marker)

1/2021	The EGFR Polymorphism Increased the Risk of Hepatocellular Carcinoma Through the miR-3196-Dependent Approach in Chinese Han Population.
1/2021	CSE1L silencing impairs tumor progression via MET/STAT3/PD-L1 signaling in lung cancer.
1/2019	A Panel of Three Biomarkers Identified by iTRAQ for the Early Diagnosis of Pancreatic Cancer.
1/2019	Fecal Metabolomics and Potential Biomarkers for Systemic Lupus Erythematosus.
4/2012	Expressions of p53, c-MYC, BCL-2 and apoptotic index in human osteosarcoma and their correlations with prognosis of patients.
3/2012	Low expression of Beclin 1, associated with high Bcl-xL, predicts a malignant phenotype and poor prognosis of gastric cancer.
9/2011	Aberrant upregulation of 14-3-3ơ expression serves as an inferior prognostic biomarker for gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xing Wu Research Topics

Disease

37	Neoplasms (Cancer) 03/2024 - 01/2004
21	Infections 11/2023 - 01/2008
14	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2021 - 06/2011
13	Inflammation (Inflammations) 04/2024 - 09/2012
10	Colitis 04/2024 - 04/2019
9	Leukemia 11/2023 - 06/2006
7	Cardiotoxicity 01/2020 - 01/2005
6	Stomach Neoplasms (Stomach Cancer) 01/2023 - 09/2011
6	Glioma (Gliomas) 04/2016 - 02/2008
6	Osteosarcoma (Osteogenic Sarcoma) 02/2015 - 11/2004
5	Osteoarthritis 08/2022 - 11/2018
5	Wounds and Injuries (Trauma) 01/2020 - 06/2011
5	Atherosclerosis 04/2015 - 06/2011
4	COVID-19 06/2023 - 09/2021
4	Carcinogenesis 01/2022 - 09/2011
4	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2014
4	Hepatitis E 01/2020 - 10/2016
4	Hypertrophy 09/2019 - 01/2016
4	Hyperglycemia 11/2017 - 11/2012
3	Necrosis 01/2022 - 01/2020
3	Virus Diseases (Viral Diseases) 01/2022 - 04/2011
3	Osteoporosis 12/2020 - 09/2011
3	Hematoma 06/2020 - 10/2017
3	Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease) 01/2020 - 12/2015
3	Hypoxia (Hypoxemia) 08/2018 - 01/2013
3	Reperfusion Injury 01/2017 - 05/2008
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2015 - 05/2011
3	Ischemia 10/2012 - 05/2008
2	Severe Acute Respiratory Syndrome 04/2024 - 01/2023
2	Pain (Aches) 07/2023 - 01/2021
2	Nociceptive Pain 05/2023 - 01/2021
2	ST Elevation Myocardial Infarction 05/2023 - 01/2016
2	Lung Injury 10/2022 - 01/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2019
2	Dehydration (Water Stress) 01/2022 - 12/2019
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 05/2017
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2020
2	Ulcerative Colitis 10/2021 - 06/2021
2	Pancreatitis 11/2020 - 01/2020
2	Diabetes Mellitus 05/2017 - 01/2017
2	Fibrosis (Cirrhosis) 02/2017 - 08/2003
2	Hepatitis B 08/2016 - 08/2008

Drug/Important Bio-Agent (IBA)

19	VaccinesIBA 04/2024 - 06/2013
14	Proteins (Proteins, Gene)FDA Link 06/2023 - 11/2004
7	AcidsIBA 11/2022 - 10/2007
7	Long Noncoding RNAIBA 01/2022 - 11/2018
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2011
6	Dextran SulfateIBA 04/2024 - 04/2019
6	Neutralizing AntibodiesIBA 04/2024 - 01/2017
6	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 04/2012
5	Therapeutic UsesIBA 05/2023 - 05/2017
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2003
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2005
4	IronIBA 02/2023 - 01/2005
4	Antiviral Agents (Antivirals)IBA 11/2022 - 02/2012
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022 - 09/2009
4	MicroRNAs (MicroRNA)IBA 10/2022 - 09/2019
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2008
4	Factor VII (Proconvertin)IBA 09/2021 - 01/2014
4	Fibrinogen (Factor I)FDA Link 01/2020 - 06/2011
4	Phosphotransferases (Kinase)IBA 01/2017 - 12/2012
4	Type II DNA Topoisomerases (Topoisomerase II)IBA 02/2016 - 06/2006
3	CytokinesIBA 10/2022 - 10/2020
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2022 - 01/2005
3	Amino Acids FDA Link 01/2022 - 01/2010
3	Messenger RNA (mRNA)IBA 05/2021 - 02/2018
3	AnthracyclinesIBA 01/2020 - 01/2005
3	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2020 - 01/2017
3	antineoplaston A10 (A 10)IBA 01/2020 - 01/2018
3	AnnexinsIBA 01/2019 - 01/2016
3	recombinant FVIIa (rFVIIa)FDA Link 01/2017 - 06/2013
3	Indicators and Reagents (Reagents)IBA 03/2012 - 01/2008
2	SteroidsIBA 05/2024 - 01/2015
2	Circular RNAIBA 07/2023 - 08/2022
2	SilverIBA 05/2023 - 01/2021
2	LipopolysaccharidesIBA 01/2023 - 01/2022
2	SaltsIBA 01/2023 - 04/2016
2	Pattern Recognition ReceptorsIBA 11/2022 - 01/2022
2	Aconitic Acid (Aconitate)IBA 01/2022 - 12/2019
2	Phosphates (Orthophosphate)IBA 01/2022 - 09/2009
2	Methionine (L-Methionine)FDA Link 01/2022 - 12/2019
2	SugarsIBA 01/2022 - 12/2019
2	Contrast MediaIBA 12/2020 - 02/2017
2	Arginine (L-Arginine)FDA Link 11/2020 - 01/2020
2	CollagenIBA 01/2019 - 07/2016
2	Protein Isoforms (Isoforms)IBA 01/2019 - 02/2016
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 08/2018 - 07/2012
2	CarbonIBA 07/2018 - 01/2010
2	fibrin fragment D (D-dimer)IBA 01/2018 - 06/2011
2	poly-N-4-vinylbenzyllactonamideIBA 01/2018 - 01/2013
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2017 - 11/2012
2	Tyrosine Kinase InhibitorsIBA 01/2017 - 03/2013

Therapy/Procedure

19	Therapeutics 05/2023 - 10/2012
3	Drug Therapy (Chemotherapy) 01/2022 - 02/2016
3	Transplantation 07/2018 - 02/2008
2	Moxibustion 05/2023 - 05/2017
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 05/2017
2	Knee Replacement Arthroplasty (Total Knee Replacement) 05/2017 - 01/2017
2	Injections 08/2016 - 01/2015